The Cost-Effectiveness of Adding Helicobacter Pylori Screening to the National Gastric Cancer Screening Program in Korea: Protocol for a Cost-Effectiveness Modeling Study
JMIR Research Protocols · 2025
DOI: 10.2196/72228 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Seowoo Bae und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Stomach Neoplasms, Helicobacter pylori, Helicobacter Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
In Korea, the National Cancer Screening Program (NCSP) was implemented in 1999 and provides biennial endoscopy for adults aged ≥40 years. The NCSP has contributed to the early detection of gastric cancer and reduction of associated mortality in Korea. Helicobacter pylori is the main cause of gastric cancer. Screening for and eradication of H pylori reduces the incidence and mortality of gastric cancer. Previous studies have reported that screening for H pylori is a cost-saving intervention that can significantly decrease gastric cancer burden in areas with a high prevalence of H pylori infection. However, no study has examined whether incorporating H pylori screening into national endoscopic screening is cost effective.
Objective
This study aims to evaluate the cost-effectiveness of incorporating H pylori screening into Korea’s National Gastric Cancer Screening Program.
Methods
We have developed a Markov model to compare two strategies: (1) endoscopy screening every 2 years starting at the age of 40 years (conventional screening), and (2) H pylori screening at the age of 40 years followed by continuous endoscopy screening every 2 years. We will also conduct a comparative analysis by varying the age at which the H pylori screening is performed. The primary outcome is the incremental cost-utility ratio (ICUR), calculated by dividing the incremental cost by the incremental quality-adjusted life-years (QALYs) between the two strategies. A probabilistic sensitivity analysis will be performed to test the uncertainty of the cost-effectiveness results. A sensitivity analysis will identify the most influential variables for cost-effectiveness.
Results
The primary outcome parameter is the cost-effectiveness of adding H pylori testing to the current NCSP, which is expressed as the ICUR. Costs and utilities are discounted at an annual rate of 4.5%. The ICUR threshold is set at KRW 50 million (US $36,719), which is the South Korean gross domestic product per capita. This research has been funded by a Patient-Centered Clinical Research Coordinating Center grant from the Ministry of Health & Welfare, Republic of Korea (grant RS-2024-00398474). This study will analyze and synthesize previously published information and is thus exempt from institutional review board approval. Data collection started in June 2024 and was completed in May 2025. Study results will be published in peer-reviewed journals and presented at national and international conferences throughout 2025.
Conclusions
We will examine whether introducing H pylori testing and eradication therapy into the NCSP is a more cost-effective strategy for reducing gastric cancer risk than conventional endoscopy-based screening. Our study also examines the optimal age for H pylori screening, as well as the optimal screening frequency. International Registered Report Identifier (IRRID) DERR1-10.2196/72228
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea.
- Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
- Center for Gastric Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
- Department of Internal Medicine and Institute of Medical Science, College of Medicine, Gyeongsang National University and Hospital, Jinju, Republic of Korea.
- Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Republic of Korea.
ORCID-Profile: Seowoo Bae, Joon Sung Kim, Moon Won Lee, Gwang Ha Kim, Young-Il Kim, Woon Tae Jung, Gwang Ho Baik, Beom Jin Kim, Joongyub Lee, Mina Suh, Jae Gyu Kim
Zitieren
APA
Bae, S., Kim, J. S., Lee, M. W., Kim, G. H., Kim, Y. I., Jung, W. T., Baik, G. H., Kim, B. J., Lee, J., Suh, M., & Kim, J. G. (2025). The Cost-Effectiveness of Adding Helicobacter Pylori Screening to the National Gastric Cancer Screening Program in Korea: Protocol for a Cost-Effectiveness Modeling Study. JMIR Research Protocols. https://doi.org/10.2196/72228
Vancouver
Bae S, Kim JS, Lee MW, Kim GH, Kim YI, Jung WT, et al. The Cost-Effectiveness of Adding Helicobacter Pylori Screening to the National Gastric Cancer Screening Program in Korea: Protocol for a Cost-Effectiveness Modeling Study. JMIR Research Protocols. 2025. doi:10.2196/72228
BibTeX
@article{Bae2025,
author = {Bae, Seowoo and Kim, Joon Sung and Lee, Moon Won and Kim, Gwang Ha and Kim, Young-Il and Jung, Woon Tae and Baik, Gwang Ho and Kim, Beom Jin and Lee, Joongyub and Suh, Mina and Kim, Jae Gyu},
title = {The Cost-Effectiveness of Adding Helicobacter Pylori Screening to the National Gastric Cancer Screening Program in Korea: Protocol for a Cost-Effectiveness Modeling Study},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/72228}
}
EUVIMED